PSC Breaking News, Episode 1: Major Updates at EASL 2025

PSC Breaking News, Episode 1: Major Updates at EASL 2025

In the inaugural episode of the PSC Breaking News podcast, Stephen Rossi and Brian Thorsen from PSC Partners sit down and discuss three major results presented at the EASL Congress from May 7-10, 2025 in Amsterdam, Netherlands. These include Phase II and Phase III studies for potential treatments for PSC, and a groundbreaking study for new blood tests for earlier detection of cholangiocarcinoma (bile duct cancer, or CCA) in PSC. PSC Partners is encouraged by these three major positive pieces of news, which offer hope to those affected by this serious disease. We will continue to share more information regarding these studies and trials as it becomes available. 00:00 - 05:38: Introduction and EASL Overview 05:38 - 11:42: Elafibranor Phase II Results 11:42 - 21:52: Norucholic Acid (norUrso) Phase III Results 21:52 - 28:57 : CCA Early Detection Presentation